Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer

van Veggel, B. (B.), van der Wekken, A. (A.), Hashemi, S. (S.), R. Cornelissen (Robin), K. Monkhorst (Kim), D.A.M. Heideman (Danielle), Radonic, T. (T.), E.F. Smit (Egbert), E. Schuuring (Ed) and De Langen, J. (J.)

2018-10-01

Annals of Oncology , Volume 29 p. viii524- viii525

Additional Metadata
Persistent URL	doi.org/10.1093/annonc/mdy292.072, hdl.handle.net/1765/125545
Journal	Annals of Oncology
Organisation	Department of Pulmonology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Veggel, B. (B.), van der Wekken, A. (A.), Hashemi, S. (S.), Cornelissen, R., Monkhorst, K., Heideman, D., … De Langen, J. (J.). (2018). Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer. Annals of Oncology, 29, viii524–viii525. doi:10.1093/annonc/mdy292.072

Publication